quinazolines has been researched along with butyric acid in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Leon Carrion, S; Sutter, CH; Sutter, TR | 1 |
| Fujita, M; Hara, M; Ito, Y; Kanemitsu, Y; Kondo, E; Nakanishi, H; Nakata, S; Tanaka, H; Yatabe, Y | 1 |
2 other study(ies) available for quinazolines and butyric acid
| Article | Year |
|---|---|
Combined treatment with sodium butyrate and PD153035 enhances keratinocyte differentiation.
Topics: Antineoplastic Agents; Butyric Acid; Cell Differentiation; Cells, Cultured; Epidermal Growth Factor; ErbB Receptors; Filaggrin Proteins; Histamine Antagonists; Humans; Intermediate Filament Proteins; Keratinocytes; Quinazolines; RNA, Messenger; Transglutaminases | 2014 |
Deficient HER3 expression in poorly-differentiated colorectal cancer cells enhances gefitinib sensitivity.
Topics: Animals; Antineoplastic Agents; Butyric Acid; Cell Cycle; Cell Differentiation; Cell Line, Tumor; Colorectal Neoplasms; ErbB Receptors; Gefitinib; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Mice, Nude; Quinazolines; Receptor, ErbB-2; Receptor, ErbB-3; Xenograft Model Antitumor Assays | 2014 |